Concepedia

Pier Paolo Sainaghi

PP

Statistics

Publications

96

Citations

5.8K

H-Index

37

Active since

2003

Affiliations

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”(Current)

Azienda Ospedaliero Universitaria Maggiore della Carita

Istituti di Ricovero e Cura a Carattere Scientifico

University of Pavia

King's College London

Pier Paolo Sainaghi is an author at Università degli Studi del Piemonte Orientale “Amedeo Avogadro” specializing in medicine, infectious diseases, and immunology.

ORCID

Publications per year

2003–2023

96

Publications

96

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia

Carlo Salvarani, Giovanni Dolci, Marco Massari et al. · JAMA Internal Medicine · 2020 · 733 citations · Full text

, , +14

Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge

Mattia Bellan, Daniele Soddu, Piero Emilio Balbo et al. · JAMA Network Open · 2021 · 495 citations · Full text

, , +13

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Frances Humby, Patrick Durez, Maya H Buch et al. · The Lancet · 2021 · 315 citations · Full text

, , +17

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Felice Rivellese, Anna E. A. Surace, Katriona Goldmann et al. · Nature Medicine · 2022 · 279 citations · Full text

, , +17

Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2

Elettra Barberis, Sara Timo, Elia Amede et al. · International Journal of Molecular Sciences · 2020 · 243 citations · Full text

, , +7

1–5 of 96